Allison Dorval

Board Director

Director

Puma Biotechnology, Inc.Verve Therapeutics, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 1 saleJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (4 ops.)

€101k

Latest filing published 15 Jun 2026 for Puma Biotechnology, INC.. Read the official filing

Filing timeline

BuySale

Allison Dorval

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Allison Dorval: trading record in brief

Allison Dorval is a declared insider at 2 companies (board member); the most frequent names are Puma Biotechnology, Inc. and Verve Therapeutics, Inc. In total, 13 filings cover trades dated from 14 June 2022 to 12 June 2026.

Every open-market trade on record is a sale: 4 sales worth €101k. The totals exclude 1 filing filed without an amount. Other entries cover 4 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 1 sale.

The newest entry dates from 15 June 2026: a share grant, in Puma Biotechnology, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.